IROKO. COMMITTED TO RESPONSIBLE
PAIN MANAGEMENT

At Iroko, our focus is offering treatment options to help address patient needs in pain management.

Today, we have an FDA-approved diclofenac created using SoluMatrix Fine Particle Technology.

In addition, we offer 2 dosage forms of the established NSAID indomethacin, designed to help patients who may need an alternative to tablet or capsule pain relievers.

Current US Products
Current Products Marketed Globally

If you wish to receive information about a product or want to report an adverse event or concern about the quality of an Iroko prescription product, call 1-877-757-0676 or contact us.

SoluMatrix Fine Particle Technology™ is a trademark of iCeutica Inc., and is licensed to Iroko for exclusive use in NSAIDs.

Products